key: cord-0979306-22nf5mk6
authors: Newman, R.; Jagannadha Sastry, K.
title: Antiviral effects of oleandrin
date: 2021-06-09
journal: J Am Coll Emerg Physicians Open
DOI: 10.1002/emp2.12469
sha: d71d3a0372a53aa2a188069601497050de6659a0
doc_id: 979306
cord_uid: 22nf5mk6

More importantly, our published studies demonstrated the safety of the plant extract in the Food and Drug Administration (FDA)-approved Phase I and II clinical trials in cancer patients through the use of our novel drug PBI-05204. [...]that is our current aim for PBI-05204. With respect to oleandrin and extracts containing this molecule, we point out that although toxicity can result in the use of high doses of this molecule, when used appropriately either for cancer or, as suggested, for treatment of certain viral-mediated diseases (including envelope viruses), the compound can be used with both safety and, we hope to prove, clinical efficacy.

We read with great interest the article entitled "Toxicity of herbal medications suggested as treatments for COVID-19: a narrative review" by M.A. DiPietro and C. Mondie that appeared in JACEP Open highlighting the reported use of certain herbal medications, some specifically suggested as treatments for COVID-19. 1 Although we concur with the cautionary note in the article regarding plant-derived medications that, although possibly effective, can exhibit significant toxicity, we would also note that, as the Father of Toxicology (Paracelsus) is reported to have written: "Only the dose makes the poison." Certainly, depending on the dosage, use of cardiac glycosides can have the potential to cause severe cardiovascular toxicities. However, the use of digoxin (Lanoxin) at appropriate doses to treat congestive heart failure has been an accepted therapeutic strategy for many years. Harking back to Paracelsus, "only the dose makes the poison" could easily be said to be true for hundreds of current FDA-approved medications. With respect to oleandrin and extracts containing this molecule, we point out that although toxicity can result in the use of high doses of this molecule, when used appropriately either for cancer or, as suggested, for treatment of certain viral-mediated diseases (including envelope viruses), the compound can be used with both safety and, we hope to prove, clinical efficacy.

Toxicity of herbal medications suggested as treatment for COVID-19: a narrative

Antiviral effects of oleandrin

Nerium oleander derived cardiac glycoside oleandrin is a novel inhibitor of HIV infectivity

The botanical glycoside oleandrin inhibits human T-cell leukemia virus type-1 infectivity and env-dependent virological synapse formation

Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2

First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors

A phase II, single-arm, openlabel, bayesian adaptive efficacy and safety study of PBI-05204 in patients with stage IV metastatic pancreatic adenocarcinoma